An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/a...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/a...